Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The first 25 patients.

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on May 22, 2023 2:34pm

221 Views

Post# 35459238

RE:RE:The first 25 patients.

Would have to agree with you Apophis, something had to change in what FDA wanted or else we would have BTD by now since it was supposed to be applied for 1st quarter, not complaining because it appears as time goes on on numbers improve, and i also feel we will get both BTD and Aa together, hopefully by 4th quarter without big dilution

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant